guanabenz has been researched along with sephin1 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Barry, N; Bertolotti, A; D'Antonio, M; Das, I; Krzyzosiak, A; Schneider, K; Sigurdardottir, A; Wrabetz, L | 1 |
Clayton, BLL; Popko, B | 1 |
Chambers, JE; Crespillo-Casado, A; Fischer, PM; Marciniak, SJ; Ron, D | 1 |
Bertolotti, A; Carrara, M; Sigurdardottir, A | 1 |
Bollen, M; Choy, MS; Claes, Z; Crespillo-Casado, A; Peti, W; Ron, D | 1 |
Chen, Y; Jones, J; Kunjamma, RB; Lin, W; Miller, SD; Podojil, JR; Popko, B; Weiner, M | 1 |
Beck, C; Bertagnoli, S; Bessière, P; Dupré, G; Eléouët, JF; Fusade-Boyer, M; Gallardo, F; Khiar, S; Lajoie, B; Lecollinet, S; Quentin-Froignant, C; Rameix-Welti, MA; Tangy, F; Vidalain, PO; Volmer, R | 1 |
Abdelaziz, DH; Abdulrahman, BA; Schatzl, HM; Thapa, S | 1 |
Andreopoulou, E; Callejo, G; Chakrabarti, S; Greenhalgh, JC; Hockley, JRF; Pattison, LA; Rahman, T; Smith, ESJ | 1 |
Alberdi, E; Luchena, C; Matute, C; Ortiz-Sanz, C; Ruiz, A; Zuazo, J | 1 |
Abbink, TEM; Bartelink, I; Bugiani, M; de Veij Mestdagh, CF; Hoogterp, L; Hu-A-Ng, GV; Krzywańska, AM; Marinus, K; Oudejans, E; van der Knaap, MS; Witkamp, D; Žnidaršič, M | 1 |
1 review(s) available for guanabenz and sephin1
Article | Year |
---|---|
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Demyelinating Diseases; Endoplasmic Reticulum Stress; Guanabenz; Humans; Neuroglia; Unfolded Protein Response | 2016 |
10 other study(ies) available for guanabenz and sephin1
Article | Year |
---|---|
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Charcot-Marie-Tooth Disease; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Guanabenz; HeLa Cells; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Phosphorylation; Protein Folding; Protein Phosphatase 1; Proteostasis Deficiencies; Signal Transduction | 2015 |
PPP1R15A-mediated dephosphorylation of eIF2α is unaffected by Sephin1 or Guanabenz.
Topics: Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Guanabenz; Protein Phosphatase 1; Protein Processing, Post-Translational | 2017 |
Decoding the selectivity of eIF2α holophosphatases and PPP1R15A inhibitors.
Topics: Eukaryotic Initiation Factor-2; Guanabenz; Humans; Membrane Proteins; Protein Binding; Protein Conformation; Protein Phosphatase 1; Recombinant Proteins | 2017 |
A Sephin1-insensitive tripartite holophosphatase dephosphorylates translation initiation factor 2α.
Topics: Actins; Animals; Catalytic Domain; Drug Resistance; Eukaryotic Initiation Factor-2; Gene Expression Regulation; Guanabenz; HeLa Cells; Humans; Phosphorylation; Protein Isoforms; Protein Phosphatase 1; Proteolysis; Rabbits | 2018 |
Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
Topics: Animals; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Humans; Immunity, Innate; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; Rats | 2019 |
Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections.
Topics: Animals; Antiviral Agents; Cell Line; DNA Viruses; Eukaryotic Initiation Factor-2; Guanabenz; Humans; Mice; Phosphorylation; Poxviridae Infections; Rabbits; RNA Viruses; Tumor Virus Infections; Virus Replication | 2019 |
Sephin1 Reduces Prion Infection in Prion-Infected Cells and Animal Model.
Topics: Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Synergism; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Guanabenz; Metformin; Mice; Neuroblastoma; Neuroprotective Agents; Phosphorylation; Prions; Protein Phosphatase 1; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; PrPC Proteins; PrPSc Proteins; Scrapie; Unfolded Protein Response | 2020 |
In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3.
Topics: Acid Sensing Ion Channels; Allosteric Regulation; Animals; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Guanabenz; Guanidines; Protein Structure, Secondary; Quinazolines | 2020 |
Sephin1 Protects Neurons against Excitotoxicity Independently of the Integrated Stress Response.
Topics: Animals; Calcium; Cells, Cultured; Cytoprotection; Embryo, Mammalian; Endoplasmic Reticulum Stress; Guanabenz; N-Methylaspartate; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Physiological | 2020 |
Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1.
Topics: Adrenergic Agents; Animals; Eukaryotic Initiation Factor-2B; Guanabenz; Mice; White Matter | 2022 |